Our April 29, 2021 webinar featured Professor Jürgen Götz, Ph.D. presenting:
“FUS in Neurodegenerative Disorders"
View the lecture from the following link:
Professor Jürgen Götz is Foundation Chair of Dementia Research and Director of the Clem Jones Centre for Ageing Dementia Research at the Queensland Brain Institute (University of Queensland). He performed undergraduate studies at the Biocenter of the University of Basel, before joining the laboratory of Nobel Laureate Georges Köhler to obtain his PhD degree in immunology. Subsequently, he took up postdoctoral positions at UCSF (San Francisco) and Sandoz Ltd (now Novartis, Basel), and worked as Research Group Leader (venia legendi, Dr. habil.) at the University of Zurich (Switzerland). Before taking up his current position, Götz was a Professor and Chair of Molecular Biology at the University of Sydney. Götz is an expert in basic research in Alzheimer's disease (AD), focusing on the cellular and molecular mechanisms of how tau and Aβ cause neurodegeneration, using transgenic and cellular models (>200 publications, including in leading journals such as Science, Cell and Neuron (h-index 72, Google Scholar). More recently, Götz developed a non-pharmacological ultrasound-based treatment strategy that removes toxic Aβ and tau in mice and restores memory functions, presenting ultrasound as a novel treatment modality for diseases of the brain.
This session was moderated by Elisa E. Konofagou from Columbia University. Professor Konofagou designs and develops ultrasound-based technologies for automated estimation of tissue mechanics as well as drug delivery and therapeutics. Her group has worked on the design of algorithms that can estimate minute deformation as a result of physiological function, such as in the heart and vessels, and displacements induced by the ultrasound wave itself, such as in tumors and nerves, while she maintains several collaborations with physicians in order to translate these technologies to the clinical setting. She has also developed novel techniques in order to facilitate noninvasive brain drug delivery as well as modulation of both the central and peripheral nervous systems.
We want to extend our gratitude to our Industry Partner for this webinar.
Please visit their online exhibit booth to learn more about their products.
